Search
Now showing items 1-1 of 1
Use of low cell dose for unmanipulated donor lymphocyte for management of cytomegalovirus infection: a single-center experience
(2020)
Although advancements have been made in monitoring and preventing viral infections in HSCT patients, CMV reactivation still remains a critical post-transplant complication. Adoptive cell therapy is an alternative to ...